RSS Feeds
Search

Press releases

Press releases

Displaying 1..8 of 8 - per page
Order by
On January 15th 2003, the European Patent Office has granted final patent protection (EP 1275377A1) to APR's proprietary technology for the preparation of granulates containing liposoluble substances. More
Dr David Rees becomes Director of Medicinal Chemistry at Astex More
Phase I trial with antidiabetic drug P93/01 concluded More
Morphochem AG and Xenogen Corp. today announced that both companies have entered into a research collaboration to discover targets and develop compounds effective against bacterial biofilms. More
Discoveries may identify novel strategies for targeting and inhibiting the key protein Protein Tyrosine Phosphatase 1B (PTP1B) More
Morphochem and GBF have entered into a research collaboration in the area of cancer research, the objective of which is to develop new therapeutics using tubulysins. More
STOCKHOLM, SWEDEN—Her Majesty the Queen of Sweden will officially open the Salk Institute's annual International Council meeting at the Grand Hotel in Stockholm. More
Another significant milestone for CRESTOR - for lowering LDL Cholesterol More
Displaying 1..8 of 8 - per page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us